ENDOSALPINGIOSIS

ENDOSALPINGIOSIS was reported 11 times

ENDOSALPINGIOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin Antagonist [EPC] 2 0.0004
1 Vitamin D3 Analog [EPC] 1 0.0000
2 Insulin [EPC] 1 0.0000
3 Copper-containing Intrauterine Device [EPC] 1 0.0000
4 Folate Analog [EPC] 1 0.0000
5 Vitamin A [EPC] 1 0.0000
6 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
7 Nicotinic Acid [EPC] 1 0.0000
8 Antidote [EPC] 1 0.0000
9 Cardiac Glycoside [EPC] 1 0.0000
10 Calcium [EPC] 2 0.0000
11 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
12 Estrogen [EPC] 2 0.0000
13 Proteasome Inhibitor [EPC] 1 0.0000
14 Sulfonylurea [EPC] 1 0.0000
15 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
16 Leukocyte Growth Factor [EPC] 1 0.0000
17 Interferon beta [EPC] 1 0.0000
18 Expectorant [EPC] 1 0.0000
19 Opioid Agonist [EPC] 1 0.0000
20 Progestin [EPC] 1 0.0000
21 Vitamin D [EPC] 1 0.0000
22 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
23 Vitamin B12 [EPC] 1 0.0000
24 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
25 Benzodiazepine [EPC] 2 0.0000
26 Vitamin C [EPC] 1 0.0000
27 Insulin Analog [EPC] 1 0.0000
28 Proton Pump Inhibitor [EPC] 1 0.0000
29 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000